Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro

[1]  C. Eaves,et al.  Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome. , 2004, Blood.

[2]  J. Bertho,et al.  Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. , 2004, Blood.

[3]  D J Prockop,et al.  Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Deeg,et al.  Negative Regulators of Hemopoiesis and Stroma Function in Patients with Myelodysplastic Syndrome , 2000, Leukemia & lymphoma.

[5]  E. Solary,et al.  A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes , 1999, Leukemia.

[6]  N. Takahashi,et al.  Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. , 1998, Blood.

[7]  D. Horsman,et al.  Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation. , 1998, Blood.

[8]  G. Verhoef,et al.  Patients with high‐risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission , 1998, British journal of haematology.

[9]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[10]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[11]  C. Preudhomme,et al.  Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes , 1995, British journal of haematology.

[12]  E. Macintyre,et al.  Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. , 1995, Blood.

[13]  J. Chang,et al.  Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndrome (MDS) , 1990, British journal of haematology.

[14]  H. Kantarjian,et al.  Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.